NGVT
VENTE TOTALE: 20 092 titres (~1 526 423,32 $ US)
- Insiders
- Li David H
- Total bought
- —
- Total sold
- $1,526,423
- Last activity
- 2026-08-18
- Last synced
-
2026-08-25 17:08:49
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-16
NGVT's Q2 2026 earnings beat and raised EBITDA guidance represent a genuine short-term catalyst, but a confidence-adjusted catalyst score of ~45 cannot offset an extremely weak fundamental base (avg.
The first sentence of the analysis written for NGVT on 2026-08-16 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 39.5% | 32.3% | 27.9% | 34.2% | 36.9% | |
| Ebit Margin | -5.9% | -31.1% | 4.9% | 19.9% | 15.4% | |
| Ebitda Margin | 3.2% | -23.4% | 12.2% | 26.4% | 23.3% | |
| Operating Profit Margin | 22.4% | 18.5% | 15.2% | 20.4% | 22.1% | |
| Pretax Profit Margin | -12.2% | -38.1% | -0.6% | 16.2% | 11.7% | |
| Continuous Operations Profit Margin | -12.9% | -30.6% | -0.3% | 12.7% | 8.5% | |
| Net Profit Margin | -14.3% | -30.6% | -0.3% | 12.7% | 8.5% | |
| Bottom Line Profit Margin | -14.3% | -30.6% | -0.3% | 12.7% | 8.5% | |
| Current Ratio | 1.331 | 1.867 | 1.815 | 2.251 | 2.696 | |
| Quick Ratio | 0.786 | 1.126 | 0.964 | 1.148 | 1.799 | |
| Solvency Ratio | -0.037 | -0.176 | 0.059 | 0.157 | 0.127 | |
| Cash Ratio | 0.229 | 0.257 | 0.264 | 0.253 | 1.024 | |
| Price To Earnings Ratio | -12.837 | -3.439 | -314.800 | 12.807 | 24.141 | |
| Price To Earnings Growth Ratio | 0.210 | -0.000 | 3.064 | 0.150 | -0.746 | |
| Forward Price To Earnings Growth Ratio | 0.210 | -0.000 | 3.064 | 0.150 | -0.746 | |
| Price To Earnings Diluted Ratio | -12.837 | -3.439 | -314.800 | 12.807 | 24.305 | |
| Price To Earnings Diluted Growth Ratio | 0.210 | -0.000 | 3.064 | 0.148 | -0.748 | |
| Price To Book Ratio | 72.132 | 7.583 | 2.729 | 3.881 | 4.235 | |
| Price To Sales Ratio | 1.835 | 1.052 | 1.018 | 1.624 | 2.051 | |
| Price To Free Cash Flow Ratio | 7.833 | 29.023 | 18.083 | 15.857 | 15.059 | |
| Price To Operating Cash Flow Ratio | 6.468 | 11.510 | 8.402 | 8.647 | 9.729 | |
| Debt To Assets Ratio | 0.753 | 0.719 | 0.585 | 0.559 | 0.536 | |
| Debt To Equity Ratio | 41.842 | 7.452 | 2.430 | 2.192 | 1.964 | |
| Debt To Capital Ratio | 0.977 | 0.882 | 0.708 | 0.687 | 0.663 | |
| Long Term Debt To Capital Ratio | 0.973 | 0.864 | 0.687 | 0.678 | 0.650 | |
| Financial Leverage Ratio | 55.593 | 10.362 | 4.155 | 3.919 | 3.664 | |
| Working Capital Turnover Ratio | 6.828 | 5.360 | 5.010 | 3.992 | 3.231 | |
| Operating Cash Flow Ratio | 0.970 | 0.487 | 0.565 | 1.033 | 1.091 | |
| Operating Cash Flow Sales Ratio | 0.284 | 0.091 | 0.121 | 0.188 | 0.211 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.826 | 0.397 | 0.465 | 0.545 | 0.646 | |
| Debt Service Coverage Ratio | 0.235 | -1.409 | 1.186 | 6.096 | 3.923 | |
| Interest Coverage Ratio | 3.397 | 2.657 | 2.748 | 5.518 | 5.942 | |
| Short Term Operating Cash Flow Coverage Ratio | 7.032 | 2.098 | 2.430 | 348.222 | 14.964 | |
| Operating Cash Flow Coverage Ratio | 0.267 | 0.088 | 0.134 | 0.205 | 0.222 | |
| Capital Expenditure Coverage Ratio | 5.740 | 1.657 | 1.868 | 2.199 | 2.826 | |
| Dividend Paid And Capex Coverage Ratio | 5.740 | 1.657 | 1.868 | 2.199 | 2.826 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 88.420 | -8.701 | 15.349 | 9.459 | 12.027 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 39.5% | ▲7.2% | ▲5.4% |
| Ebit Margin | -5.9% | ▲25.2% | ▼-6.5% |
| Ebitda Margin | 3.2% | ▲26.6% | ▼-5.1% |
| Operating Profit Margin | 22.4% | ▲4.0% | ▲2.7% |
| Pretax Profit Margin | -12.2% | ▲25.9% | ▼-7.6% |
| Continuous Operations Profit Margin | -12.9% | ▲17.7% | ▼-8.3% |
| Net Profit Margin | -14.3% | ▲16.3% | ▼-9.5% |
| Bottom Line Profit Margin | -14.3% | ▲16.3% | ▼-9.5% |
| Current Ratio | 1.331 | ▼-0.537 | ▼-0.661 |
| Quick Ratio | 0.786 | ▼-0.340 | ▼-0.379 |
| Solvency Ratio | -0.037 | ▲0.139 | ▼-0.063 |
| Cash Ratio | 0.229 | ▼-0.029 | ▼-0.177 |
| Price To Earnings Ratio | -12.837 | ▼-9.399 | ▲45.988 |
| Price To Earnings Growth Ratio | 0.210 | ▲0.211 | ▼-0.326 |
| Forward Price To Earnings Growth Ratio | 0.210 | ▲0.211 | ▼-0.326 |
| Price To Earnings Diluted Ratio | -12.837 | ▼-9.399 | ▲45.955 |
| Price To Earnings Diluted Growth Ratio | 0.210 | ▲0.211 | ▼-0.325 |
| Price To Book Ratio | 72.132 | ▲64.549 | ▲54.020 |
| Price To Sales Ratio | 1.835 | ▲0.782 | ▲0.319 |
| Price To Free Cash Flow Ratio | 7.833 | ▼-21.190 | ▼-9.338 |
| Price To Operating Cash Flow Ratio | 6.468 | ▼-5.042 | ▼-2.483 |
| Debt To Assets Ratio | 0.753 | ▲0.033 | ▲0.122 |
| Debt To Equity Ratio | 41.842 | ▲34.389 | ▲30.666 |
| Debt To Capital Ratio | 0.977 | ▲0.095 | ▲0.193 |
| Long Term Debt To Capital Ratio | 0.973 | ▲0.109 | ▲0.203 |
| Financial Leverage Ratio | 55.593 | ▲45.231 | ▲40.054 |
| Working Capital Turnover Ratio | 6.828 | ▲1.468 | ▲1.944 |
| Operating Cash Flow Ratio | 0.970 | ▲0.483 | ▲0.141 |
| Operating Cash Flow Sales Ratio | 0.284 | ▲0.192 | ▲0.105 |
| Free Cash Flow Operating Cash Flow Ratio | 0.826 | ▲0.429 | ▲0.250 |
| Debt Service Coverage Ratio | 0.235 | ▲1.644 | ▼-1.771 |
| Interest Coverage Ratio | 3.397 | ▲0.739 | ▼-0.656 |
| Short Term Operating Cash Flow Coverage Ratio | 7.032 | ▲4.934 | ▼-67.917 |
| Operating Cash Flow Coverage Ratio | 0.267 | ▲0.178 | ▲0.084 |
| Capital Expenditure Coverage Ratio | 5.740 | ▲4.083 | ▲2.882 |
| Dividend Paid And Capex Coverage Ratio | 5.740 | ▲4.083 | ▲2.882 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 88.420 | ▲97.121 | ▲65.109 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $2.14B | $1.48B | $1.72B | $2.71B | $2.85B | |
| Enterprise value | $3.31B | $2.87B | $3.16B | $4.16B | $3.90B | |
| EV / Sales | 2.83x | 2.04x | 1.87x | 2.50x | 2.80x | |
| EV / Op. cash flow | 9.98x | 22.29x | 15.42x | 13.29x | 13.30x | |
| EV / Free cash flow | 12.09x | 56.21x | 33.18x | 24.36x | 20.59x | |
| EV / EBITDA | 88.42x | -8.70x | 15.35x | 9.46x | 12.03x | |
| Net debt / EBITDA | 31.14x | -4.21x | 6.98x | 3.30x | 3.23x | |
| Current ratio | 1.33x | 1.87x | 1.81x | 2.25x | 2.70x | |
| Income quality | -1.98x | -0.30x | -37.98x | 1.48x | 2.48x | |
| Graham number | — | — | — | $47 | $34 | |
| Graham net-net | -$37 | -$42 | -$43 | -$42 | -$32 | |
| Tax burden | 117.6% | 80.3% | 53.5% | 78.5% | 72.5% | |
| Interest burden | 205.9% | 122.3% | -12.1% | 81.4% | 75.9% | |
| Working capital | $112.9M | $229.1M | $295.7M | $379.8M | $456.0M | |
| Invested capital | $970.3M | $1.42B | $2.04B | $2.21B | $2.05B | |
| Return on assets | -10.1% | -21.3% | -0.2% | 7.7% | 4.8% | |
| Operating ROA | 14.3% | 11.2% | 9.6% | 13.1% | 12.8% | |
| Return on tangible assets | -11.7% | -28.2% | -0.3% | 12.0% | 7.2% | |
| Return on equity | -562.6% | -220.4% | -0.9% | 30.3% | 17.5% | |
| Return on invested capital | 19.1% | 11.4% | 5.8% | 10.9% | 10.0% | |
| Return on capital employed | 20.0% | 14.8% | 11.3% | 14.0% | 14.0% | |
| Earnings yield | -7.8% | -29.1% | -0.3% | 7.8% | 4.1% | |
| Free cash flow yield | 12.8% | 3.4% | 5.5% | 6.3% | 6.6% | |
| Capex / Op. cash flow | 17.4% | 60.3% | 53.5% | 45.5% | 35.4% | |
| Capex / Depreciation | 54.2% | 71.7% | 89.4% | 131.0% | 94.4% | |
| Capex / Sales | 4.9% | 5.5% | 6.5% | 8.5% | 7.5% | |
| SG&A / Sales | 14.7% | 11.9% | 10.9% | 11.9% | 12.9% | |
| R&D / Sales | 2.4% | 2.0% | 1.9% | 1.8% | 1.9% | |
| Stock comp / Sales | 1.6% | 0.8% | 0.6% | 1.0% | 0.9% | |
| Intangibles / Total assets | 13.3% | 24.7% | 34.8% | 35.6% | 33.2% | |
| Days sales outstanding | 49d | 42d | 46d | 55d | 50d | |
| Days payables outstanding | 48d | 36d | 47d | 58d | 52d | |
| Operating cycle | 145d | 117d | 138d | 166d | 150d | |
| Cash conversion cycle | 98d | 81d | 91d | 108d | 98d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+44.7%EV / Sales ▲+38.9%EV / EBITDA ▲+1116.2%EV / Op. cash flow ▼-12.308Earnings yield ▲+0.213
Profitability
Return on equity ▼-3.422Return on assets ▲+0.112Return on invested capital ▲+0.078Return on capital employed ▲+0.052Operating ROA ▲+0.031Income quality ▼-1.683Tax burden ▲+0.373
Efficiency
Days sales outstanding ▲+7.104Days payables outstanding ▲+11.314Operating cycle ▲+28.120Cash conversion cycle ▲+16.806Capex / Sales ▼-0.006R&D / Sales ▲+0.004
Balance-sheet strength
Current ratio ▼-0.537Net debt / EBITDA ▲+35.348Working capital ▼-116200000.000Invested capital ▼-445500000.000Intangibles / Total assets ▼-0.114
Change over 5 years
Valuation
Market cap ▼-24.9%EV / Sales ▲+1.0%EV / EBITDA ▲+635.2%EV / Op. cash flow ▼-3.317Earnings yield ▼-0.119
Profitability
Return on equity ▼-5.802Return on assets ▼-0.149Return on invested capital ▲+0.092Return on capital employed ▲+0.060Operating ROA ▲+0.015Income quality ▼-4.466Tax burden ▲+0.451
Efficiency
Days sales outstanding ▼-0.876Days payables outstanding ▼-4.699Operating cycle ▼-4.919Cash conversion cycle ▼-0.221Capex / Sales ▼-0.025R&D / Sales ▲+0.005
Balance-sheet strength
Current ratio ▼-1.365Net debt / EBITDA ▲+27.909Working capital ▼-343100000.000Invested capital ▼-1078500000.000Intangibles / Total assets ▼-0.199
Employee count
Peer market caps
Congressional trades
No congressional trade data synced.
Recent news
- 2026-08-18 Ingevity included in TIME America''s Best Companies 2026 list NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity included in TIME America''s Best Companies 2026 list.
- 2026-08-06 NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes Ingevity''s Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting higher 2026 earnings and EBITDA guidance.
- 2026-08-05 Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact Ingevity Corporation (NYSE: NGVT) today announced it has published its [url="]2025 Sustainability Report[/url] featuring the company''s advanced materials and tec
- 2026-08-05 Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation has published its 2025 Sustainability Report titled “A Decade of Performance, a Future of Possibility.".
- 2026-07-31 Ingevity Q2 Earnings Call Highlights Ingevity NYSE: NGVT reported second-quarter 2026 results marked by higher adjusted earnings, margin expansion and progress on its portfolio simplification efforts, as the company raised its full-year adjusted EBITDA and earnings-per-share outlook.
- 2026-07-31 Bank of New York Mellon Corp Has $15.03 Million Stake in Ingevity Corporation $NGVT Bank of New York Mellon Corp reduced its stake in shares of Ingevity Corporation (NYSE: NGVT) by 6.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 211,002 shares of the company''s stock after selling 13,808 shares during the quarter.
- 2026-07-30 Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
- 2026-07-29 Ingevity (NGVT) Tops Q2 Earnings and Revenue Estimates Ingevity (NGVT) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.39 per share a year ago.
- 2026-07-29 Ingevity reports second quarter 2026 financial results NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year.
- 2026-07-17 NGVT''s Evotherm P35 Gets German Approval for Warm-Mix Asphalt Use Ingevity''s Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.